Predictive Oncology Inc (AIPT) Stock
AIPT is no longer traded. Predictive Oncology was delisted from the Nasdaq in June 2022.
Prices on this page are historical; the last trade was June 3, 2022 at $0.46.
Predictive Oncology stock price history
AIPT final trading statistics
- Final close
- $0.46
- Final trading day
- Jun 3, 2022
- Market cap at delisting
- —
- Shares outstanding
- —
- Final 52-week range
- $0.25 – $1.64
- Avg. volume (final 3 mo.)
- 1,001,030
- All-time high (split-adj.)
- $262500.00 · Jul 2011
- All-time low (split-adj.)
- $5.40 · May 2022
- Return since IPO
- -100.0%
- Beta
- —
- Book value / share
- —
- Price / book
- —
Predictive Oncology annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2018 | $1.41M | -$10.1M | — |
| FY2017 | $654.8K | -$6.0M | — |
| FY2016 | $456.5K | -$6.5M | — |
| FY2015 | $654.4K | -$4.8M | — |
| FY2014 | $952.0K | -$6.8M | — |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Predictive Oncology Inc
Precision Therapeutics Inc. provides various healthcare products and services primarily in the United States. The company manufactures environmentally conscious systems for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. It offers the STREAMWAY Fluid Waste Management system that suctions surgical waste fluid from the patient using standard surgical tubing; and disposables. The company also provides contract research organization (CRO) that offers personalized medicine solutions for pharmaceutical, diagnostic, and biotech industries. Its CRO services enhance the effectiveness of cancer therapy using the power of artificial intelligence applied to diseases databases. The company markets and sells its STREAMWAY Fluid Waste Management system and procedure disposables to medical facilities through various direct sales force and independent distributors. The company was formerly known as Skyline Medical Inc. and changed its name to Precision Therapeutics Inc. in February 2018. Precision Therapeutics Inc. was founded in 2002 and is based in Eagan, Minnesota.
Predictive Oncology stock FAQ
What happened to Predictive Oncology stock?
Predictive Oncology stock was delisted from the Nasdaq. Its final close was $0.46 on June 3, 2022.
Is AIPT stock still trading?
No. AIPT was delisted from the Nasdaq in June 2022 and no longer trades on a U.S. exchange.
What was the last price of AIPT stock?
AIPT closed at $0.46 on its final trading day, June 3, 2022.
What were Predictive Oncology's revenue and earnings in its last full fiscal year?
Predictive Oncology reported revenue of $1.41M and net income of -$10.1M in fiscal 2018, its last full year as a public company.
When did Predictive Oncology go public?
Predictive Oncology Inc stock began trading on July 21, 2010.